🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase II trial tests how well a survivin peptide vaccine called SurVax...
Status
Not Yet Recruiting
Location
Rocky Mountain Regional VA Medical Center
Start Date
2026-10-01
Trial ID
NCT07169617
This study involves cancer research and the purpose is to assess the safety...
Status
Completed
Location
Rockefeller University
Start Date
2007-06
Trial ID
NCT00893945
Treatments Being Tested
This research study uses radiation or a gene therapy agent, TNFerade in add...
Status
Terminated
Location
East Carolina University - Leo W. Jenkins Cancer Center
Start Date
2006-07
Trial ID
NCT00868114
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Status
Completed
Location
Biomira Inc.
Start Date
1999-01
Trial ID
NCT00003638
Treatments Being Tested
Background: The mainstay of therapy for newly diagnosed multiple myeloma p...
Status
Completed
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2001-02-08
Trial ID
NCT00006184
The purpose of this study is to assess the safety and activity of DC/PC3, a...
Status
Completed
Location
Rockefeller University Hospital
Start Date
2006-06
Trial ID
NCT00345293
Treatments Being Tested
The purpose of this study is to determine if a dendritic cell vaccine made ...
Status
Unknown
Location
Loyola Univeristy Medical Center, Cardinal Bernardin Cancer Center
Start Date
2008-10
Trial ID
NCT00703105
Treatments Being Tested
Both patients and marrow donors are treated on Regimen A; patients then pro...
Status
Completed
Location
National Cancer Institute (NCI)
Start Date
1996-11
Trial ID
NCT00001561
Treatments Being Tested
The main purpose of this study is to determine whether adding SurVaxM to st...
Status
Unknown
Location
University of California
Start Date
2021-11-18
Trial ID
NCT05163080
Treatments Being Tested
RATIONALE: Vaccines may make the body build an immune response to kill tumo...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
1998-06
Trial ID
NCT00003819
Treatments Being Tested